Latest news with #PMCK
BusinessToday
09-07-2025
- Business
- BusinessToday
Bursa Opens Steady As Key Indices Inch Higher
The Malaysian stock market opened on a steady note this morning, with the benchmark FBM KLCI rising marginally by 0.38 points or 0.02% to 1,530.52 as of 9.01am. Broader market indices also saw modest gains. The FBM 70 added 5.96 points to 16,543.86, while the FBM Emas ticked up 3.10 points to 11,471.24. The F4GBM index inched up 0.26 points to 927.81, and the FBM Shariah Index gained 1.22 points to 11,433.66. Market sentiment was mixed, with trading volume led by PM Consolidated Holdings (PMCK), which saw 160.5 million shares exchanged as the stock rose 0.5 sen to 22.5 sen. Pharmaniaga gained 1 sen to 15.5 sen, while TWL Holdings dipped 0.5 sen to 2.5 sen. Borneo Oil and Scope remained unchanged at 0.5 sen and 9 sen respectively. Overall, the cautious tone reflected investors' wait-and-see approach ahead of key economic data and policy signals. Related
New Straits Times
07-07-2025
- Business
- New Straits Times
PMCK to post steady earnings growth through FY27
KUALA LUMPUR: Private healthcare provider PMCK Bhd is expected to register higher core earnings from financial year 2024 (FY24) to FY27, supported by room upgrades and stronger revenue intensity. Hong Leong Investment Bank (HLIB) said it projects PMCK's core earnings to grow at a compound annual growth rate (CAGR) of 3.8 per cent over the three-year period. The firm is scheduled for listing on Wednesday, aiming to raise RM67 million from its initial public offering at 22 sen per share. HLIB said values PMCK at 22 sen per share, based on a 10 times enterprise value-to-earnings before interest, taxes, depreciation and amortisation (Ebitda) multiple on its 2026 forecast. "This reflects a 25 per cent discount to the sector average of 13.5 times," HLIB said in a note, adding that the discount is warranted as PMCK has a more limited geographic presence, mainly concentrated in Kedah. It said unlike IHH Healthcare Bhd and KPJ Healthcare Bhd, which offer tertiary care, PMCK primarily operates as a community hospital providing secondary care and its projected three-year earnings CAGR of 3.8 per cent lags behind IHH's 9.7 per cent and KPJ's 9.2 per cent. PMCK is a private healthcare provider delivering a wide array of services, which include specialist consultant care, healthcare support and various medical service segments. These additional services encompass general dental care, polyclinic treatments, and medical laboratory testing. At present, PMCK runs a 121-bed private medical centre, along with a polyclinic, two dental clinics and a medical laboratory.
The Star
30-06-2025
- Business
- The Star
PMCK IPO oversubscribed 1.87 times ahead of ACE Market listing on July 9
KUALA LUMPUR: PMCK Bhd's initial public offering (IPO) has been oversubscribed by 1.87 times for the Malaysian public portion, ahead of its listing on the ACE Market of Bursa Malaysia on July 9. The company said it has received a total of 2,512 applications for 156.25 million IPO shares worth RM34.37 million from the Malaysian public, which represented an overall oversubscription rate of 1.87 times. "For the Bumiputera public portion, a total of 993 applications for 23.09 million IPO shares were received, where the balance has been clawed back and re-allocated to the public (portion),' it said in a media statement. PMCK said 43.62 million IPO shares made available for application by the eligible persons have also been fully subscribed, while 136.32 million IPO shares by way of private placement to Bumiputera investors approved by MITI have been fully placed out after applying the relevant clawback and reallocation provisions as set out in PMCK's prospectus. "Furthermore, 38.12 million IPO shares and 32.72 million existing shares by way of private placement to selected investors have been fully placed out,' it added. The notices of allotment will be posted to all successful applicants on July 7, 2025. - Bernama
The Star
20-06-2025
- Business
- The Star
PMCK poised for growth with IPO plans
PETALING JAYA: PMCK Bhd, a private healthcare provider enroute to listing on the ACE Market of Bursa Malaysia, intends to pay at least 20% of its net profit as a dividend going forward. TA Research assumes a dividend payout of 20% to 44% across financial year 2025 (FY25) to FY27 and projects forward yields to be at 1.3% to 2.1%. TA Research said for its initial public offering (IPO) price of 22 sen a share, PMCK is priced at a trailing price earnings ratio (PE) of 15.9 times based on FY24 earnings per share (EPS). The research house forecast a target PE of 16 times FY26 EPS for the counter, while deriving a fair value of 23 sen a share. PMCK is operating the Putra Medical Centre in Alor Setar, Kedah and has been in the business for over 30 years, offering specialist consultant services and clinical support, with 40 consultants across 17 specialisations. PMCK will raise RM60mil through its IPO on Bursa Malaysia. It wants to strengthen its presence in northern Malaysia to attract patients and drive long-term revenue growth. Thus far, Kedah has one of the lowest private hospital bed densities in Malaysia, highlighting a significant gap in private healthcare access. As part of its expansion, PMCK is constructing a new medical centre, PMC Kulim, with operations targeted to start by the first quarter of financial year 2028 (1Q28). The 12-storey private medical centre comes with a seven-storey mixed development comprising a four-storey hotel with a two-storey food court and carparks. PMCK will consolidate the RYM DX Laboratory Sdn Bhd (medical lab) into PMC Kulim by 1Q28 to cater to increasing demand for diagnostic services. It will upgrade the equipment and facilities in PMC Kedah under clinical support services (medical lab) and facilities services (radiology unit). TA Research projects net profit to contract by 24.8% to RM11.3mil in FY25, as it expects patient numbers to drop by 20% due to the flooding in Alor Setar and surrounding areas, which hindered patient access. It expects the profit after tax margin to decline to 12.1% (versus 14.4% in FY24) due to softer patient volumes and higher administrative expenses as PMCK's facilities remained fully operational during the heavy rainfall between September and December 2024.
New Straits Times
26-05-2025
- Business
- New Straits Times
Alor Setar-based PMCK to raise nearly RM60mil from ACE Market IPO
KUALA LUMPUR: Private healthcare service provider PMCK Bhd aims to raise RM59.97 million from its initial public offering (IPO) ahead of a planned listing on the ACE Market of Bursa Malaysia on July 9. The IPO entails a public issue of 272.6 million new shares at an issue price of 22 sen each, alongside an offer for sale of 32.7 million existing shares via private placement, according to the company's prospectus launched today. Based on the enlarged share capital of 1.09 billion shares at the IPO price, PMCK is expected to have a market capitalisation of approximately RM239.93 million upon listing. Of the public issue, 54.53 million shares are allocated to the Malaysian public, 43.62 million to eligible directors, employees and contributors to the group's success, 136.33 million to approved Bumiputera investors, and 38.12 million to selected investors. Founded in Alor Setar, PMCK operates a 121-bed private medical centre offering specialist consultant services, inpatient and outpatient care, clinical diagnostics and pharmacy services. It also runs dental and polyclinic facilities, along with a medical laboratory business under RYM DX Lab. PMCK is optimistic about its growth prospects, underpinned by plans to expand its presence in Kedah through a new 12-storey private medical centre in Kulim. The group also intends to upgrade medical equipment at its existing Alor Setar facility and consolidate its ancillary operations for greater efficiency. It expects demand for private healthcare to remain resilient, supported by demographic shifts, increasing insurance coverage and a shortage of hospital beds in the northern region. In 2024, the group recorded RM104.3 million in revenue, with more than 75 per cent contributed by inpatient services. Proceeds from the IPO will be used to repay borrowings, acquire medical equipment, fund renovations and expansion, and cover working capital and listing-related expenses. Malacca Securities is the principal adviser, sponsor, underwriter and joint placement agent, while Kenanga Investment Bank is a joint placement agent. Applications for the public tranche open today and will close at 5pm on June 25.
